TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03623217

Intervention type: BEHAVIORAL
Intervention: Qualitative interviews with participants
Description: For the development and validation of a questionnaire.
Study: NCT02374008

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Study: NCT01087424

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: R mini CHOP
Description: Prednisone 40 mg/m2 D1 D2 D3 D4 D5 Rituximab 375 mg/m2 D1 Doxorubicine 25 mg/m2 D1 Cyclophosphamide 400 mg/m2 D1 Vincristine 1 mg/m2 D1
Study: NCT03618797

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HL-PIF cap.160/2mg + Placebo
Description: Fenofibrate pellet (as micronized fenofibrate 160mg) and Pitavastatin Ca 2mg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Livalo tab. 2mg + Placebo
Description: Pitavastatin ca 2mg
Study: NCT02660918

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Description: Paracervical injection of 20 mL 0.25% Bupivacaine at the completion of the procedure

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: Equal volume injection of normal saline with the same paracervical technique
Study: NCT03291912

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chuna Manual Therapy
Description: * Unique manual therapy in traditional Korean medicine~* Mandatory techniques for neck part and selective techniques for other part (if necessary)~* Selective techniques depends on a patient's condition (judged by traditional Korean medicine doctor)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Usual care
Description: 1. Physical therapy based on traditional Korean medicine theory~   * Electrical stimulation: either Meridian muscle interferential current electricity or Meridian transcutaneous electricity~  * Heat stimulation: either Hot pack or Infrared lamp~2. Patient education~   * Physical and pathological explanation of cervicogenic dizziness~  * Cause and risk factors of cervicogenic dizziness~  * Functions of muscles related to cervicogenic dizziness~  * Home exercising to self-manage cervicogenic dizziness
Study: NCT02185196

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 20,000 IU Miglyol-oil in children \<6 months, 50,000 IU in children 6-12 months and 1,00,000 IU in children 13-59 months of age on first day and thereafter 10,000 IU for next 4 days
Study: NCT01003873

Intervention type: BIOLOGICAL
Intervention: Evaluation of the endocannabinoid system
Description: The evaluation of the endocannabinoid system consist in the determination of plasma concentration of the 2 main endocannabinoids (2AG and AEA) before (5 blood samples) and after (5 blood samples) after consumption of a calibrated food. As a comparator, ghrelin will be measured at the same time.

Intervention type: BIOLOGICAL
Intervention: Evaluation of the endocannabinoid system
Description: The evaluation of the endocannabinoid system consist in the determination of plasma concentration of the 2 main endocannabinoids (2AG and AEA) before (5 blood samples) and after (5 blood samples) after consumption of a calibrated food. As a comparator, ghrelin will be measured at the same time.

Intervention type: BIOLOGICAL
Intervention: Evaluation of the endocannabinoid system
Description: The evaluation of the endocannabinoid system consist in the determination of plasma concentration of the 2 main endocannabinoids (2AG and AEA) before (5 blood samples) and after (5 blood samples) after consumption of a calibrated food. As a comparator, ghrelin will be measured at the same time.

Intervention type: PROCEDURE
Intervention: Biopsy of visceral and peripheral adipose tissue
Description: The endocannabinoids will be also determined in adipose tissue. Biopsy of visceral and peripheral adipose tissue will be done during surgery and peripheral adipose tissue will be done 6 months after surgery.

Intervention type: BIOLOGICAL
Intervention: Evaluation of metabolic parameters
Description: The evaluation of the metabolic status consist in evaluation of body composition (DEXA), determination of visceral adiposity (CT scan) and measurement of plasma lipids, glucose, insulin, leptin, adiponectin.

Intervention type: BIOLOGICAL
Intervention: Evaluation of metabolic parameters
Description: The evaluation of the metabolic status consist in evaluation of body composition (DEXA), determination of visceral adiposity (CT scan) and measurement of plasma lipids, glucose, insulin, leptin, adiponectin.
Study: NCT00616889

Intervention type: DRUG
Intervention: Seroquel
Description: The dosage is flexible from 50-600 mg based on the investigator's clinical judgement and patient tolerance. It may be raised or lowered at will.
Study: NCT04984694

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computerized virtual reality training programs group (Hot-Plus group)
Description: In this study, the investigators utilised interactive-video games called Xavix Hot Plus(Hot-plus, Shinsedai\[SSD\] Co. Ltd, Shiga Japan), which was designed specifically for rehabilitation and reported high participant motivation and enjoyment while playing.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social interaction group
Description: The social interaction group will get together as a group for social interaction one hour weekly for 12 weeks.
Study: NCT01717729

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency Ablation
Description: For RFA, we used a commercially available system (RF 2000; Radio Therapeutics, Mountain View, Calif) and a needle electrode with a 15-gauge insulated cannula that had 10 hook-shaped expandable electrode tines with a diameter of 3.5 cm at expansion (LeVeen; Radio Therapeutics).The radioactivity per seed ranged from 0.5 to 0.6 millicuries (mCi)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Radiofrequency Ablation
Description: For RFA, we used a commercially available system (RF 2000; Radio Therapeutics, Mountain View, Calif) and a needle electrode with a 15-gauge insulated cannula that had 10 hook-shaped expandable electrode tines with a diameter of 3.5 cm at expansion (LeVeen; Radio Therapeutics).The radioactivity per seed ranged from 0.5 to 0.6 millicuries (mCi)

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: iodine
Description: The 125I seeds (0.8 mm in diameter and 4.5mm in length) were enclosed in a NiTinol capsule (China Institute of Atomic Energy, Beijing). These seeds could produce 27.4-31.5 keV X-ray and 35.5 Kev γ ray, with a half-life of 59.6 days. The radioactivity per seed ranged from 0.5 to 0.6 millicuries (mCi).
Study: NCT01053169

Intervention type: BIOLOGICAL
Intervention: Beriplex® P/N
Description: Intravenous infusion, the dosage and the frequency of administration is calculated on an individual patient basis.

Intervention type: BIOLOGICAL
Intervention: Beriplex® P/N
Description: Intravenous infusion, the dosage and the frequency of administration is calculated on an individual patient basis.

Intervention type: BIOLOGICAL
Intervention: Fresh Frozen Plasma (FFP) and Beriplex® P/N
Description: FFP is administered before Beriplex® P/N. Each treatment is given as an intravenous infusion, with the dosage of each calculated on an individual patient basis.

Intervention type: BIOLOGICAL
Intervention: Fresh Frozen Plasma (FFP) and Beriplex® P/N
Description: FFP is administered before Beriplex® P/N. Each treatment is given as an intravenous infusion, with the dosage of each calculated on an individual patient basis.

Intervention type: OTHER
Intervention: Fresh Frozen Plasma
Description: Intravenous infusion, the dosage and the frequency of administration is calculated on an individual patient basis.
Study: NCT01003873

Intervention type: BIOLOGICAL
Intervention: Evaluation of metabolic parameters
Description: The evaluation of the metabolic status consist in evaluation of body composition (DEXA), determination of visceral adiposity (CT scan) and measurement of plasma lipids, glucose, insulin, leptin, adiponectin.

Intervention type: BEHAVIORAL
Intervention: Evolution of behavioral parameters
Description: The behavioral evaluation will de done with different questionnaires: ORWELL 97, HAD scale, Three Factor Eating Questionnaire, Beck Depression inventory, Questionnaire of personality TCI.

Intervention type: BEHAVIORAL
Intervention: Evolution of behavioral parameters
Description: The behavioral evaluation will de done with different questionnaires: ORWELL 97, HAD scale, Three Factor Eating Questionnaire, Beck Depression inventory, Questionnaire of personality TCI.

Intervention type: BEHAVIORAL
Intervention: Evolution of behavioral parameters
Description: The behavioral evaluation will de done with different questionnaires: ORWELL 97, HAD scale, Three Factor Eating Questionnaire, Beck Depression inventory, Questionnaire of personality TCI.

Intervention type: BEHAVIORAL
Intervention: Dietician consultation
Description: The evaluation of the metabolic status will also be seen by a dietician.
Study: NCT01053169

Intervention type: OTHER
Intervention: Fresh Frozen Plasma
Description: Intravenous infusion, the dosage and the frequency of administration is calculated on an individual patient basis.
Study: NCT00798161

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1356
Description: BI 1356 high dose tablet, once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1356 + metformin
Description: BI 1356 low dose tablet + Metformin 500 mg tablet, twice daily
Study: NCT01003873

Intervention type: BEHAVIORAL
Intervention: Dietician consultation
Description: The evaluation of the metabolic status will also be seen by a dietician.

Intervention type: BEHAVIORAL
Intervention: Psychologist consultation
Description: The behavioural evaluation will de done with a psychologist consultation

Intervention type: BEHAVIORAL
Intervention: Psychologist consultation
Description: The behavioural evaluation will de done with a psychologist consultation
Study: NCT02414958

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT00798161

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bi 1356 + metformin
Description: BI 1356 low dose tablet + Metformin 1000 mg tablet, twice daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: Metformin 500 mg tablet, twice daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: metformin
Description: metformin 1000 mg tablet, twice daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: matching placebo
Description: matching placebo
Study: NCT03291912

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: 1. Physical therapy based on traditional Korean medicine theory~   * Electrical stimulation: either Meridian muscle interferential current electricity or Meridian transcutaneous electricity~  * Heat stimulation: either Hot pack or Infrared lamp~2. Patient education~   * Physical and pathological explanation of cervicogenic dizziness~  * Cause and risk factors of cervicogenic dizziness~  * Functions of muscles related to cervicogenic dizziness~  * Home exercising to self-manage cervicogenic dizziness
Study: NCT03996785

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Walking in Urban setting
Description: Walking for 60 minutes as described above

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Walking in nature setting
Description: Walking for 60 minutes as described above
Study: NCT02566915

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CPET submaximal with EPAP
Description: The expiratory positive pressure is applied through silicone mask (RHDSON Vital Signs®, New Jersey, USA) containing one-way valve and a resistance mechanism expiratory positive expiratory pressure generator adjustable 5-20 cm H2O (Spring Loaded) (Vital Signs® , New Jersey, USA). The mask one headgear will be comfortably adjusted to face being used to prevent air leakage, and the pressure level gradually adjusted to the level of 10 cm H2O.
Study: NCT03632798

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ChemoID assay
Description: The ChemoID test is a CLIA-certified and CAP-accredited drug response assay performed by a hospital clinical pathology laboratory that uses patient's live tumor cells to indicate which chemotherapy agent (or combinations) will kill not only bulk of tumor cells, but importantly the cancer stem cells (CSCs) that are known to cause cancer to recur. During the assay, cancer stem cells and bulk tumor cells from an individual patient are exposed to FDA-approved chemotherapy drugs.~The test measures the cytotoxic effect of actual doses of standard-of-care chemotherapies. The ChemoID drug response assay reports a prioritized list of effective and ineffective chemotherapies. The test is designed to target cancer stem cells to mitigate tumor relapse.
Study: NCT01404468

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: pulsed ultrasound device with lidocaine
Description: Lidocaine (approximately 2 cc) was administered transdermally using a transducer (pulsed ultrasound)
Study: NCT03632798

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: ChemoID assay
Description: The ChemoID test is a CLIA-certified and CAP-accredited drug response assay performed by a hospital clinical pathology laboratory that uses patient's live tumor cells to indicate which chemotherapy agent (or combinations) will kill not only bulk of tumor cells, but importantly the cancer stem cells (CSCs) that are known to cause cancer to recur. During the assay, cancer stem cells and bulk tumor cells from an individual patient are exposed to FDA-approved chemotherapy drugs.~The test measures the cytotoxic effect of actual doses of standard-of-care chemotherapies. The ChemoID drug response assay reports a prioritized list of effective and ineffective chemotherapies. The test is designed to target cancer stem cells to mitigate tumor relapse.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Chemotherapies chosen by Physician or ChemoID assay are in the same list of FDA approved drugs to treat recurrent ovarian cancer.~Chemotherapy list:~* Liposomal Doxorubicin;~* Docetaxel;~* Paclitaxel;~* Carboplatin;~* Cisplatin;~* Gemcitabine;~* Topotecan;~* Carboplatin, Gemcitabine;~* Cisplatin, Gemcitabine;~* Carboplatin, Liposomal Doxorubicin;~* Carboplatin, Paclitaxel;~* Carboplatin, Docetaxel.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy
Description: Chemotherapies chosen by Physician or ChemoID assay are in the same list of FDA approved drugs to treat recurrent ovarian cancer.~Chemotherapy list:~* Liposomal Doxorubicin;~* Docetaxel;~* Paclitaxel;~* Carboplatin;~* Cisplatin;~* Gemcitabine;~* Topotecan;~* Carboplatin, Gemcitabine;~* Cisplatin, Gemcitabine;~* Carboplatin, Liposomal Doxorubicin;~* Carboplatin, Paclitaxel;~* Carboplatin, Docetaxel.
Study: NCT02341872

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clinpro White Varnish (fluoride + calcium varnish)
Description: Clinpro White Varnish will be applied to the teeth with brush.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinpro White Varnish (fluoride + calcium varnish)
Description: Clinpro White Varnish will be applied to the teeth with brush.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Curodont Repair
Description: Curodont Repair solution be applied to the teeth in the form of drops
Study: NCT01404468

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: off device
Description: off device with Lidocaine (approximately 2 cc) was administered transdermally
Study: NCT02341872

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Curodont Repair
Description: Curodont Repair solution be applied to the teeth in the form of drops
Study: NCT04369885

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Go Home tablet with linked GoSpiro and 3230 Pulse Oximeter
Description: All participants will receive the intervention consisting of a home telemedicine tablet platform (GoHome) that will collect multiple spirometry tests each week (including both forced and slow spirometry measurements), pulse oximetry, and QoL Questionnaire responses. The platform will remind patients to take their medications remind patients to perform measurements, send patients helpful information, and execute a UNC clinic established COPD Action Plan.The backend of the platform is a remote server (Monitored Therapeutics CarePortal) that collects the data, send out alerts to the Principal Investigator and can track and trend the data for them.
Study: NCT00685711

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Cat-PAD
Description: single, escalating dose intradermal and subcutaneous injections of Cat-PAD
Study: NCT01404468

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: continuous ultrasound device with lidocaine
Description: Lidocaine (approximately 2 cc) was administered transdermally using a transducer (continuous ultrasound )
Study: NCT02562313

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BioChaperone insulin lispro
Description: BioChaperone insulin lispro bolus infusion followed by test meal intake

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Humalog®
Description: Humalog® bolus infusion followed by test meal intake
Study: NCT00685711

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cat-PAD
Description: single, escalating dose intradermal and subcutaneous injections of Cat-PAD

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Cat-PAD
Description: single, escalating dose intradermal and subcutaneous injections of Cat-PAD

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cat-PAD
Description: single, escalating dose intradermal and subcutaneous injections of Cat-PAD
Study: NCT02020421

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: rTMS
Description: Low frequency (1Hz) repetitive transcranial magnetic stimulation (rTMS) over the center of the right Pars Triangularis for 15 minutes (900 pulses) prior to each Speech-Language therapy session. Stimulation intensity will be set at 90% of the resting motor threshold (RMT) of the left first dorsal interosseous (FDI) muscle.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS
Description: 2mA cathodal transcranial direct current stimulation (tDCS) over the right Pars Triangularis. The anode will be placed on the forehead over the contralateral eye. tDCS will start immediately before the speech-language therapy session and last throughout the session.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham rTMS
Description: Low frequency (1Hz) repetitive transcranial magnetic stimulation (rTMS) over the Vertex for 15 minutes (900 pulses) prior to each Speech-Language therapy session. Stimulation intensity will be set at 10% of the resting motor threshold (RMT) of the left first dorsal interosseous (FDI) muscle.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham rTMS
Description: Low frequency (1Hz) repetitive transcranial magnetic stimulation (rTMS) over the Vertex for 15 minutes (900 pulses) prior to each Speech-Language therapy session. Stimulation intensity will be set at 10% of the resting motor threshold (RMT) of the left first dorsal interosseous (FDI) muscle.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham tDCS
Description: Sham cathodal transcranial direct current stimulation (tDCS) over the right Pars Triangularis. The anode will be placed on the forehead over the contralateral eye. To elicit the typical skin sensation of real tDCS (tingling sensation on the skin when tDCS is turned on and off), the current will be turned on for 30 seconds and then turned off for the duration of the speech-language therapy session. The same procedure will be done at the end of the session.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham tDCS
Description: Sham cathodal transcranial direct current stimulation (tDCS) over the right Pars Triangularis. The anode will be placed on the forehead over the contralateral eye. To elicit the typical skin sensation of real tDCS (tingling sensation on the skin when tDCS is turned on and off), the current will be turned on for 30 seconds and then turned off for the duration of the speech-language therapy session. The same procedure will be done at the end of the session.
Study: NCT02896621

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chlorthalidone plus amiloride
Description: A capsule with chlorthalidone plus amiloride was taken once daily in the morning for eight weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amlodipine
Description: A capsule of amlodipine was taken once daily in the morning for eight weeks.
Study: NCT05297149

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hippotherapy
Description: The hippotherapy program consisted of 6 weekly sessions that varied in duration between 20 and 30 minutes depending on the weekly program and the participant's condition. Each session started with brief greetings and contact with the horse.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home exrecises
Description: The home exercise program consisted of the following balance training exercises: one leg standing on foam with eyes open and closed, double leg standing on foam with eyes open and closed, walking in tandem with eyes open and closed, balance exercises on an inclined surface, balance exercises in squat, and jumping over an obstacle on the ground. All participants performed the exercises under parental supervision, 3 times per week for 6 weeks. The physiotherapist made video calls to the children and parents to ensure their adherence to the home exercise program.
Study: NCT04292756

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Subtenon injection of 40 mg triamcinolone acetonide
Description: Subtenon injection of 40 mg triamcinolone acetonide: 1 initial injection of 40 mg triamcinolone acetonide, further injections will be base at month 3 examination.
Study: NCT00554385

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABT-089
Description: Up to 4 capsules will be taken once daily for 12 months. Dosage forms include 1 mg, 5 mg, 10 mg capsules and 40 mg tablets. Highest dose allowed is 80 mg per day.